Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations

Author(s):  Trissel Lawrence A

Issue:  Nov/Dec 2008 - Arthritis and Immunological Diseases
View All Articles in Issue

Abstract:  United States Pharmacopeia Chapter <797> provides guidelines and standards that deal with the preparation, compounding, and labeling of compounded sterile preparations. These standards ensure patient care and safety by defining safe practice. The Chapter gives instructions on determining beyond-use dates for the different risk categories associated with compounded preparations. Each of these categories has specific aspects of environmental, personnel, and situational deterrents that Chapter <797> requires to be taken into account. By following the standards of Chapter <797>, compounding pharmacists can alleviate danger to the patient and themselves in any situation.

Related Keywords: Lawrence A. Trissel, BS, RPh, FASHP, United States Pharmacopeia, Chapter <797>, compounded sterile preparations, beyond use dating, quality control, standards, drug storage, sterility, drug stability, microbiological contamination risk category, risk level

Related Categories: STABILITIES, COMPATIBILITIES, STERILE PREPARATIONS, QUALITY CONTROL, UNITED STATES PHARMACOPEIA CONVENTIONS, STORAGE

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Trissel Lawrence A Nov/Dec 2008 524-528 Buy
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Allen Loyd V Jr, Okeke Claudia C Sep/Oct 2007 404-410 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use Allen Loyd V Jr, Okeke Claudia C May/Jun 2008 252-257 Buy
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Okeke Claudia C, Allen Loyd V Jr May/Jun 2010 232-238 Buy
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Newton David W, Trissel Lawrence A Jul/Aug 2004 251 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Allen Loyd V Jr, Okeke Claudia C Mar/Apr 2008 136-144 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating Allen Loyd V Jr, Okeke Claudia C Jul/Aug 2008 344-353 Buy
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Okeke Claudia C Jul/Aug 2007 302-305 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Allen Loyd V Jr, Okeke Claudia C May/Jun 2009 234-238 Buy
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards Marks Zach Mar/Apr 2014 94-99 Buy